Cancer drugs funding

Appraisal processes prevent patients from accessing new anti-cancers, report claims

A report says countries that use a QALY formula to assess cost-effectiveness have less access to new cancer drugs compared with countries that use an alternative system.…

Cancer Drugs Fund has undermined NICE, its chair admits

The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies, its chair says.…

Cost of cancer drugs

Elizabeth Sukkar, deputy news editor of The Pharmaceutical Journal, talked to BBC Radio Leicester about the cost of cancer drugs and cost of developing new medicines. She discussed the recent announcement made by NHS England that 25 clinical indications of life-extending cancer drugs will…

NHS England drops therapies from cancer drugs fund to save £80m

A total of 25 clinical indications will be removed from the government’s cancer drugs fund list, NHS England has announced.…

Criticism voiced over new rules for Cancer Drugs Fund

Cancer charities and the pharmaceutical industry have expressed concerns over the way cancer medicines are appraised after a revised process for assessing drugs available through the Cancer Drugs Fund was published by NHS England.…

Wales will not have a Cancer Drugs Fund, health minister says

Wales will not have a Cancer Drugs Fund, despite a 98,000-signature petition calling for equity of access to cancer drugs for patients in England and Wales being handed to the Welsh Assembly on 5 November 2014.…

Drug firms must price cancer drugs fairly, says charity

‘Inflated’ prices set by drug companies for breast cancer treatments are creating a barrier that no regulatory system can overcome, a cancer charity argues.…

Public call for Roche to cut price of breast cancer drug

An online petition calls on the drug company Roche to lower the price of its breast cancer drug Kadcyla to make it cheap enough to be made available on the NHS.…

NICE puts brakes on its planned overhaul of drugs evaluation processes

England’s health technology body will not push ahead with its proposed introduction of value-based assessments — including burden of illness and societal impact — in the evaluation of new drugs for use by the NHS.…

World’s most expensive drug gets green light from NICE

The National Institute for Health and Care Excellence has paved the way for making the most expensive drug in the world available on the NHS.…